Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-01-24 @ 5:27 AM
Study NCT ID:
NCT06848569
Status:
RECRUITING
Last Update Posted:
2025-02-27
First Post:
2025-02-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study
Sponsor:
Sun Yat-sen University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Classical Hodgkin Lymphoma | View |
Keywords: